Delivery Order SPE2DB22D3301-SPE2DB25FX6PY

Award Date 12/6/24
Potential Completion Date 12/9/24
Potential Value $113K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB25FX6PY
    Delivery Order

This federal contract award is a delivery order with a firm fixed price valued at $113,001.24. It was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of STELARA 90 MG/ML SYRINGEML, a specialty pharmaceutical product, with a period of performance through December 9, 2024.

Amerisourcebergen is a for-profit organization registered in the System for Award Management (SAM.gov) and has a substantial Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000, covering similar medical products and prescription drugs. These contracts demonstrate Amerisourcebergen's significant role as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems.

Generated 3/7/25, 10:08 AM